| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/01/2003 | US20030083502 Preparation of 4-haloalkylnicotinic esters |
| 05/01/2003 | US20030083500 Imidazonaphthyridines |
| 05/01/2003 | US20030083489 Method of synthesizing polynucleotides using ionic liquids |
| 05/01/2003 | US20030083476 Morphine-6-glucuronide synthesis |
| 05/01/2003 | US20030083382 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
| 05/01/2003 | US20030083374 NAALADase inhibitors useful as pharmaceutical compounds and compositions |
| 05/01/2003 | US20030083359 Treating pain, urinary incontinence and bladder overactivity; P2X receptors are cation-permeable ion channels |
| 05/01/2003 | US20030083357 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia |
| 05/01/2003 | US20030083356 Statine derivatives for the treatment of Alzheimer's disease |
| 05/01/2003 | US20030083353 Beta-secretase inhibitors |
| 05/01/2003 | US20030083345 Method of treatment and/or prevention of brain, spinal or nerve injury |
| 05/01/2003 | US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 05/01/2003 | US20030083335 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP) |
| 05/01/2003 | US20030083333 1,4-Disubstituted benzo-fused compounds |
| 05/01/2003 | US20030083332 N-heterocyclic derivatives as NOS inhibitors |
| 05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/01/2003 | US20030083312 Borating and demetallization by reacting a pyridine Grignard reagent with an alkoxydialkylborane or a trialkylborane; in situ preparing the pyridine Grignard reagent by reacting alkyl magnesium halide with a halopyridine |
| 05/01/2003 | US20030083269 Nictoinamide adenine dinucleotide (NAD); microbiocides; antiseptics; plant safening agents; antibiotic resistance; agriculture; food treatment |
| 05/01/2003 | US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease |
| 05/01/2003 | US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity |
| 05/01/2003 | CA2464256A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents |
| 05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
| 05/01/2003 | CA2463290A1 Zwitterionic imides |
| 04/30/2003 | CN1414966A Process and intermediates for preparation of imidazolidinone alpha U protein antagonists |
| 04/30/2003 | CN1414956A Substituted piperazine derivatives as MIP inhibitors |
| 04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/30/2003 | CN1107054C Method of preparation and separation of 2,4'-dipyridyl derivatives and its application |
| 04/30/2003 | CN1107049C Benzyloxy substituted aromatics and their use as fungicides and insecticides |
| 04/29/2003 | US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery |
| 04/29/2003 | US6555684 Pyrimidinyl compounds for treatment of central nervous system disorders |
| 04/29/2003 | US6555663 Prodrugs for selective drug delivery |
| 04/29/2003 | US6555580 Treating arteriosclerosis and hypercholesterolaemia |
| 04/29/2003 | US6555577 Compounds, their preparation and use |
| 04/29/2003 | US6555572 Benzylated PDE4 inhibitors |
| 04/29/2003 | US6555570 Growth hormone secretagogous with improved bioavailability |
| 04/29/2003 | US6555566 Methods and materials for treating and preventing inflammation of mucosal tissue |
| 04/29/2003 | US6555562 2-Carboxybenzoyl-(N'-3,5-dichloroisonicotinoyl)-L-4aminophenyl alanine, for example; inhibit the binding of alpha-4 integrins to their ligands, use to treat immune or inflammatory disorders |
| 04/29/2003 | US6555561 Diaminopyridine-containing thiourea inhibitors of herpes viruses |
| 04/29/2003 | US6555557 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 04/29/2003 | CA2059069C Method for preparing n-fluoropyridinium salt |
| 04/24/2003 | WO2003033490A1 Synthesis of 4-[(z)-(4-bromophenyl)(ethoxyimino)methyl]-1'-[2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine |
| 04/24/2003 | WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 04/24/2003 | WO2003033471A1 Novel pyridone derivative and remedial agent for circulatory disease containing the same |
| 04/24/2003 | WO2003033470A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 04/24/2003 | WO2003033469A1 A process for preparing beta-ketoester compound |
| 04/24/2003 | WO2003033468A1 PROCESS FOR PREPARATION OF (S)-α-HALOMETHYLPYRIDINE- METHANOL DERIVATIVES |
| 04/24/2003 | WO2003033467A1 Nitroso diphenylamine derivatives as nitrogen monoxide generating agents |
| 04/24/2003 | WO2003033461A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
| 04/24/2003 | WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032972A1 5’-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032921A2 Treatment of neurodegenerative diseases and cancer of the brain |
| 04/24/2003 | WO2003032912A2 Treatment of cns disorders using cns target modulators |
| 04/24/2003 | WO2003016282A3 Substituted 1h-dihydropyrazoles, their preparation and use |
| 04/24/2003 | WO2003000679A3 Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 04/24/2003 | US20030078287 For controlling plant and animal pests |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078266 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients |
| 04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
| 04/24/2003 | US20030078264 Treating atherosclerosis and other coronary artery diseases |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | US20030078259 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders |
| 04/24/2003 | US20030078249 VLA-4 inhibitor compounds |
| 04/24/2003 | US20030078236 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 04/24/2003 | US20030078235 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants |
| 04/24/2003 | US20030077405 Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices |
| 04/24/2003 | CA2464435A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
| 04/24/2003 | CA2463579A1 Treatment of cns disorders using cns target modulators |
| 04/24/2003 | CA2463511A1 Synthesis of 4-[(z)-(4-bromophenyl)(ethoxyimino)methyl]-1'-[2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine |
| 04/24/2003 | CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | CA2462442A1 Alkyne matrix metalloproteinase inhibitors |
| 04/23/2003 | EP1304322A2 Carboxylic acid compound and use thereof |
| 04/23/2003 | EP1304108A2 Anti-arrhythmic composition and methods of treatment |
| 04/23/2003 | EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/23/2003 | EP1303509A1 Beta3 adrenergic agonists |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303494A2 Potassium channel inhibitors |
| 04/23/2003 | EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/23/2003 | EP1303489A2 Alpha,alpha-dibromo-alpha-chloro-acetophenones as synthons |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 04/23/2003 | EP1303479A2 7-, 8- and 9-substituted tetracycline compounds |
| 04/23/2003 | EP1303308A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 04/23/2003 | EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 04/23/2003 | EP1303249A1 Antimycotic nail varnish composition |
| 04/23/2003 | EP1100783B1 Improved method for producing 2-halopyridine-n-oxide |
| 04/23/2003 | EP1007032B1 4-cyano-4-deformylsordaricin derivatives |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | EP0980236B1 Colourant and method for producing temporary hair colours |
| 04/23/2003 | EP0882715B1 Novel n-(unsubstituted or substituted)-4-substituted-6-(unsubstituted or substituted)phenoxy-2-pyridinecarboxamides or thiocarboxamides, processes for producing the same, and herbicides |
| 04/23/2003 | EP0882712B1 Process for preparing acid salts of gamma-(piperidyl)butyric acid |
| 04/23/2003 | CN1413208A Novel derivatives of 3-imino-1,2,-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 04/23/2003 | CN1413195A Immunoassay detection method for neonicotinyl insecticides |